Holen Sie sich die Stockscreener-App
1.73
1.14%
-0.02
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
66.98%
1.1763
|
0.7045 | 0.9534 | 1.0256 | 1.4582 |
| Depreciation and Amortization |
0.81%
0.0454
|
0.045 | 0.046 | 0.083 | 0.0273 |
| Operating Income/Loss |
19.55%
-2.2205
|
-1.8574 | -2.3697 | -2.0642 | -2.4106 |
| Nonoperating Income/Loss |
101.11%
0.3599
|
0.179 | 0.6493 | 0.0793 | 0.077 |
| Income/Loss From Continuing Operations Before Tax |
10.85%
-1.8605
|
-1.6785 | -1.7203 | -1.9849 | -2.3335 |
| Income Tax Expense/Benefit |
0.0008
|
- | - | - | 0.0008 |
| Income/Loss From Continuing Operations After Tax |
10.90%
-1.8613
|
-1.6785 | -1.7203 | -1.9849 | -2.3343 |
Net Income/Loss
|
10.90%
-1.8613
|
-1.6785 | 15.03 | -1.9849 | -2.3343 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | 16.75 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):